Technology to optimize pediatric diabetes management and outcomes

Current Diabetes Reports

Volumn 13, Issue 6, 2013, Pages 877-885

  Markowitz, Jessica T ^a   Harrington, Kara R ^a   Laffel, Lori M B ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

Continuous glucose monitoring; Insulin pump; Management; Outcomes; Pediatric diabetes; Psychosocial; Technology

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; DIABETES EDUCATION; DIABETES MELLITUS; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERNET; MOBILE APPLICATION; PATIENT COMPLIANCE; SELF CARE; SELF MONITORING; SOCIAL SUPPORT; TEXT MESSAGING; VIDEOCONFERENCING; VIRTUAL REALITY;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; HUMANS; INSULIN INFUSION SYSTEMS; INTERNET;

EID: 84889079391     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0419-3     Document Type: Article

References (55)

1. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
2. Laffel L, Volkening L, Hood K, Lochrie A, Nansel T, Anderson B, et al. Optimizing glycemic control in youth with T1DM: importance of BG monitoring and supportive family communication [Abstract]. Diabetes. 2006;55 Suppl 1:A197.
3. Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc. 2007;82:229-35.
4. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12:11-7.
5. Wood JR, Laffel LMB. Technology and intensive management in youth with type 1 diabetes: state of the art. Curr Diab Rep. 2007;7:104-13.
6. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34:262-7. PMCID:PMC3024331.
7. Pfutzner A, Mitri M, Musholt PB, Sachsenheimer D, Borchert M, Yap A, et al. Clinical assessment of the accuracy of blood glucose measurement devices. Curr Med Res Opin. 2012;28:525-31.
8. Recupero A, Mahnke B, Pinsker JE. Emerging technology in diabetes care: the real-time diabetes monitoring system. Mil Med. 2013;178:218-21.
9. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008;10:310-21.
10. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32:1378-83. PMCID:PMC2713649.
11. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32:1947-53. PMCID:PMC2768196.
12. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311-20.
13. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32:2245-50.
14. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2006;114:63-7.
15. Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012;35:204-10. PMCID:PMC3263860.
16. Tsalikian E, Fox L, Weinzimer S, Buckingham B, White NH, Beck R, et al. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes. 2012;13:301-7.
17. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010;12:679-84.
18. Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, et al. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 2011;28:1118-22.
19. Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther. 2012;14:523-6. PMCID:PMC3359621.
20. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA. Test manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
21. Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, et al. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes. 2012;13:449-53.
22. Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project. Diabetes Technol Ther. 2012;14:728-35.
23. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61:2230-7. PMCID:PMC3425406.
24. Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care. 2013;36:222-7. PMCID:PMC3554296.
25. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomized crossover trial. Lancet. 2010;375:743-51.
26. •• Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824-33. This group brought the study of a closed-loop system out of the lab and into a free-living environment, highlighting some novel possibilities of a system such as this.
27. Elleri D, Acerini CL, Allen JM, Hayes J, Pesterfield C, Wilinska ME, et al. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther. 2010;12:35-9.
28. van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH. Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther. 2011;13:731-6.
29. • Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile. J Diabetes Sci Technol. 2013;7:562-78. The amulatory glucose profile makes diabetes data easier to understand and may help improve glycemic control in youth and adults with diabetes.
30. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012;97(12):4383-89.
31. Beck J, Lewis T, Harrison D, Sternlof S, Comp C, Copeland K. Use of the Mastery of Stress Instrument in caregivers of children newly diagnosed with type 1 diabetes: identifying a need for further intervention. Diabetes Educ. 2012;38:280-8.
32. Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes. 2012;13:6-11.
33. • Rubin RR, Peyrot M. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther. 2012;14:143-51. This important study examined psychosocial issues related to the use of sensor-augmented insulin pump therapy.
34. Peyrot M, Rubin RR. Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med. 2013;30:464-7.
35. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, et al. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia. 2010;53:2487-95.
36. •• Ruedy KJ. The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis: diabetes research in Children Network (DirecNet) and type 1 diabetes TrialNet Study Groups. Diabetes Technol Ther. 2013;15(5). This important study examined the use of closed-loop therapy in newly diagnosed patients with T1D and it was found to be safe and effective.
37. Buckingham B, Ruedy K, Chase HP, Weinzimer S, DiMeglio L, Russell W, et al. Does intensive metabolic control at the onset of diabetes followed by one year of sensor-augmented pump therapy improve c-peptide levels one year post diagnosis? ATTD. 2013;[Late Breaking Abstracts].
38. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34:2023-5. PMCID:PMC3161284.
39. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011;13:1129-34.
40. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14:205-9.
41. van Bastelaar KM, Pouwer F, Cuijpers P, Riper H, Snoek FJ. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2011;34:320-5. PMCID:PMC3024341.
42. Stinson J, Wilson R, Gill N, Yamada J, Holt J. A systematic review of internet-based self-management interventions for youth with health conditions. J Pediatr Psychol. 2009;34:495-510.
43. Harris MA, Freeman KA, Duke DC, Hirschfield B, Boston B. Skype-based family problem solving for youth with poorly controlled diabetes: relative effectiveness of improving adherence and metabolic control. A Journal of the American Diabetes Association. 2013;62(Suppl. 1):A198.
44. Izquierdo R, Morin PC, Bratt K, Moreau Z, Meyer S, Ploutz-Snyder R, et al. School-centered telemedicine for children with type 1 diabetes mellitus. J Pediatr. 2009;155:374-9.
45. Ritterband LM, Thorndike FP, Cox DJ, Kovatchev BP, Gonder-Frederick LA. A behavior change model for internet interventions. Ann Behav Med. 2009;38:18-27. PMCID:PMC2878721.
46. Eysenbach G. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13:e126. PMCID:PMC3278112.
47. Hanauer DA, Wentzell K, Laffel N, Laffel LM. Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS call phone text messaging reminders to support diabetes management. Diabetes Technol Ther. 2009;11:99-106.
48. Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med. 2006;23:1332-8.
49. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28:455-63.
50. Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34:533-9. PMCID:PMC3041176.
51. Garcia E, Martin C, Garcia A, Harrison R, Flood D. Systematic analysis of mobile diabetes management applications on different platforms. Lect Notes Comput Sci. 2011;7058:379-96.
52. Demidowich AP, Lu K, Tamler R, Bloomgarden Z. An evaluation of diabetes self-management applications for Android smartphones. J Telemed Telecare. 2012;18:235-8.
53. Kumar VS, Wentzell KJ, Mikkelsen T, Pentland A, Laffel LM. The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. Diabetes Technol Ther. 2004;6:445-53.
54. Klingensmith GJ, Aisenberg J, Kaufman F, Halvorson M, Cruz E, Riordan ME, Varma C, Pardo S, Viggiani MT, Wallace JF, et al. Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetes. Pediatr Diabetes. 2011;14(5):350-7.
55. Nagelberg N, Shemesh Iron M. Classmate - unique edutainment software for better management of diabetes in children. ATTD Presentation. 2013. Kidney Diseases Kidney Diseases Kidney Diseases